Expertise in
6
conditions

Dr. Richard Bergenstal

Endocrinology
Park Nicollet Clinic-St Louis Park
3800 Park Nicollet Blvd, 
Minneapolis, MN 
Expertise in
6
conditions
Park Nicollet Clinic-St Louis Park
3800 Park Nicollet Blvd, 
Minneapolis, MN 

Overview

Richard Bergenstal is an Endocrinologist in Minneapolis, Minnesota. Dr. Bergenstal is highly rated in 6 conditions, according to our data. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young.

His clinical research consists of co-authoring 283 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Endocrinology

Licenses

Internal Medicine in MN

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 5 Less Insurance Carriers -

Locations

Park Nicollet Clinic-St Louis Park
3800 Park Nicollet Blvd, Minneapolis, MN 55416

Additional Areas of Focus

Dr. Bergenstal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Enrollment Status: Completed
Publish Date: February 10, 2026
Intervention Type: Drug
Study Drugs: Glimepiride, Sitagliptin, Liraglutide, Insulin (glargine)
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 3
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 03, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Degludec
Study Phase: Phase 2
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

283 Total Publications

Effects of Continuous Glucose Monitoring Discontinuation in Adults With Type 2 Diabetes Not Using Insulin.
Effects of Continuous Glucose Monitoring Discontinuation in Adults With Type 2 Diabetes Not Using Insulin.
Journal: Journal of diabetes science and technology
Published: December 30, 2025
Similar Doctors
Expertise in
4
conditions
Dr. Elizabeth Seaquist
Endocrinology
Expertise in
4
conditions
Dr. Elizabeth Seaquist
Endocrinology

Office

909 Fulton St SE Fl 3, 
Minneapolis, MN 
 (6.1 miles away)
612-625-8690
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Elizabeth Seaquist is an Endocrinologist in Minneapolis, Minnesota. Dr. Seaquist has been practicing medicine for over 44 years is highly rated in 4 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Expertise in
15
conditions
Dr. Ann Kearns
Endocrinology
Expertise in
15
conditions
Dr. Ann Kearns
Endocrinology

Hennepin Healthcare

701 Park Ave, 
Minneapolis, MN 
 (4.9 miles away)
612-873-7717
Languages Spoken:
English
See accepted insurances

Ann Kearns is an Endocrinologist in Minneapolis, Minnesota. Dr. Kearns is highly rated in 15 conditions, according to our data. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Hyperparathyroidism, Parathyroidectomy, and Hormone Replacement Therapy (HRT).

Expertise in
15
conditions
Dr. Gregory Damberg
Endocrinology
Expertise in
15
conditions
Dr. Gregory Damberg
Endocrinology

Park Nicollet Clinic-St Louis Park

3800 Park Nicollet Blvd, 
Minneapolis, MN 
 (0.1 miles away)
952-993-3622
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gregory Damberg is an Endocrinologist in Minneapolis, Minnesota. Dr. Damberg is highly rated in 15 conditions, according to our data. His top areas of expertise are Infantile Low Calcium Level, Follicular Thyroid Cancer, Thyroid Cancer, and Anaplastic Thyroid Cancer.

Frequently Asked Questions about Dr. Richard Bergenstal

How do I make an appointment with Dr. Richard Bergenstal?

You can book an appointment with Dr. Richard Bergenstal by calling their office at 952-993-3393. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard Bergenstal a top-rated expert for Low Blood Sugar?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard Bergenstal is classified as an Elite expert for Low Blood Sugar, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard Bergenstal specialize in?

While Dr. Richard Bergenstal is a Endocrinology, they have specific expertise in Low Blood Sugar, Type 2 Diabetes (T2D), and Type 1 Diabetes (T1D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Richard Bergenstal participate in research or clinical trials?

Yes. Dr. Richard Bergenstal has published 283 articles and abstracts on conditions like Low Blood Sugar. You can view a list of Dr. Richard Bergenstal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard Bergenstal accept my insurance?

Dr. Richard Bergenstal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 952-993-3393 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bergenstal's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile